pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 3
    ATSN-201
    Unspecified Ophthalmological Disorders Atsena Therapeutics Inc
  • Preclinical
    ATX-101
    T-Cell Lymphomas Abcon Therapeutics Inc
  • Phase 2
    ATX-295
    Ovarian Cancer Accent Therapeutics Inc
  • Phase 1
← prev
page 58 of 231
next →
131
Pain89
Neurology1
AU-409
Bile Duct Cancer (Cholangiocarcinoma)
Auransa Inc
  • Phase 1
    AUG-801
    Congenital Disorder of Glycosylation AUG Therapeutics LLC
  • AUGMENTIN ES-600
    AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)
    no indication US ANTIBIOTICS
  • Preclinical
    AUM-302
    Neuroblastoma AUM Biosciences Pte Ltd
  • Phase 1
    AUR-200
    Systemic Lupus Erythematosus$AUPH Aurinia Pharmaceuticals Inc.
  • Phase 1
    AUT-00201
    Myoclonic Seizure Autifony Therapeutics Ltd
  • Phase 1
    AUT-00206
    Fragile X Syndrome Autifony Therapeutics Ltd
  • Phase 2
    AUTO-3
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$AUTL Autolus Therapeutics plc
  • Phase 1
    AUTX-703
    Myelodysplastic Syndrome (Preleukemia) Auron Therapeutics Inc
  • Phase 2
    AV-0328
    Streptococcal Pneumonia Alopexx Inc
  • Phase 2
    AV-1
    Dengue Fever AbViro LLC
  • Phase 2
    AV-101
    Major Depressive Disorder$VTGN Vistagen Therapeutics, Inc.
  • Phase 1
    AV-1959D
    Alzheimer's Disease Nuravax Inc
  • Phase 1
    AV-203
    Bladder Cancer AVEO Pharmaceuticals Inc
  • Preclinical
    AVA-2206
    Cystinuria Averoa SAS
  • Phase 1
    AVA-6103
    Adenocarcinoma Of The Gastroesophageal Junction Avacta Life Sciences Ltd
  • Phase 2
    AVB-101
    Frontotemporal Dementia (Pick Disease) AviadoBio Ltd
  • Phase 2
    AVB-114
    Anal Fistula Avobis Bio LLC
  • Phase 2
    AVC-203
    Diffuse Large B-Cell Lymphoma AvenCell Therapeutics Inc
  • Phase 3
    AVD-104
    Dry (Atrophic) Macular Degeneration Aviceda Therapeutics Inc
  • Preclinical
    AVG-002
    Unspecified Respiratory Disorders AlveoGene Ltd
  • Phase 2
    AVGBM-1
    Glioblastoma Multiforme (GBM) AiVita Biomedical Inc
  • AVMAPKI FAKZYNJA CO-PACK
    AVMAPKI FAKZYNJA CO-PACK (AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE)
    no indication VERASTEM INC
  • Phase 3
    AVMEL-1
    Melanoma AiVita Biomedical Inc
  • Phase 2
    AVRRD-04
    Cystinosis$NVS NOVARTIS AG
  • AVSOLA
    AVSOLA (INFLIXIMAB-AXXQ)
    no indication$AMGN AMGEN INC
  • Phase 2
    AVT-001
    Type 1 Diabetes (Juvenile Diabetes) Avotres Inc